Podcast · Tech & Science

The BioDisruptors Podcast

by The BioDisruptors · English · Tech & Science

The BioDisruptors Podcast – Making Biotech Make Sense 🧬 Biotech is evolving fast, but keeping up shouldn’t feel like reading a textbook. We break down dense white papers and complex science into clear, engaging discussions—so you stay informed without the headache. Whether you're a biotech profess

New episodes: Weekly
Typical length: 21 min
Latest: 22 Jan 2026
Language: English

Latest episode

22 Jan 2026 · 15 min

Ep. 29 Inside the Plant Powered Pharmaceutical Factory

What if the factory of the future looks more like a greenhouse than a clean room full of steel tanks? In this episode, we explore a surprising shift in biotechnology where scientists use living plants to make vaccines, antibodies, and other critical medicines. You will learn why a humble tobacco relative has become one of the most important tools in modern biotech, how genes can be delivered into leaves in a matter of minutes, and why this approach could dramatically speed up responses to future pandemics and supply chain disruptions. Featured Article: Harnessing Transient Expression Systems…

Play episodeWhatsApp Download

Earlier episodes 29 most recent

E28 · 7 Jan 2026 · 12 min
Ep. 28 Bursting the Bubble: The Hidden Threat to Bioprocessing
Foam is more than just a nuisance! In large-scale biomanufacturing, it is a multibillion-dollar risk. This episode explores how "foaming out" can jeopardize sterility and kill the cell cultures responsible for life-saving drugs. We examine the high-stakes trade-off between foam control, cell health, and productivity. We also look at the shift toward optical monitoring, a non-invasive technology that is replacing outdated sensors to ensure process stability and maximize yield. Featured Article: Measurement and Control of Foam Generation in a Mammalian Cell Culture (…
E27 · 16 Dec 2025 · 11 min
Ep. 27 Astronaut Food to mRNA: The Radical Evolution of Lyophilization
This week, we explore the critical yet often overlooked world of lyophilization, better known as freeze drying. While you might associate it with astronaut food, it is actually the backbone of the modern pharmaceutical supply chain, stabilizing everything from mRNA vaccines to life saving biologics. We break down how the industry is ditching inefficient, decades old batch processing for a revolutionary suspended vial continuous system. By suspending vials individually, manufacturers can eliminate the effect of uneven heating, ensuring every single dose experiences identical physics. Featured…
E26 · 2 Dec 2025 · 13 min
Ep. 26 DMSO in Cell Therapy: Separating Fact from Fiction
In this episode, we break down the truth about DMSO in cell therapy, how it works, why it is used, and what the data really says about its safety. Drawing from a comprehensive review of more than 1100 patients, we explore infusion reactions, dose thresholds, and common misconceptions around DMSO toxicity. We also discuss pharmacokinetics, including the half life of DMSO, urinary elimination, and its metabolism into dimethyl sulfide. Whether you are in biotech, manufacturing, or clinical development, this episode offers a clear and evidence based look at one of the most misunderstood…
E25 · 12 Nov 2025 · 15 min
Ep. 25 The Organoid Revolution: Ending Animal Testing with Better Science
What if we could test new drugs and study diseases without using animals? In this episode, we dive into the world of organoids, mini organs grown from human cells that are reshaping biomedical research. We unpack how these tiny living systems mimic real human tissue, offering scientists a more accurate and ethical way to study biology and develop new treatments. From breakthroughs in drug testing to the promise of personalized medicine, this episode explores how organoids are driving a revolution in science that is both smarter and more humane. Featured Article: Replacing Animal Testing with…
E24 · 28 Oct 2025 · 15 min
Ep. 24 Rethinking Sterilization: Why X Ray is Gaining Ground
Can X ray sterilization really replace gamma irradiation for single use biopharma components? In this episode, we explore a recent study that directly compares the two methods across single-use bioprocessing polymers. The findings are surprising. X ray achieved the same sterilization performance as gamma while running at lower peak temperatures and creating no new extractables or measurable radioactivity. We also discuss what this means for supply chain flexibility, material stability, and the future of sterilization in biomanufacturing. The conversation clears up common misconceptions and…
E23 · 14 Oct 2025 · 15 min
Ep. 23 From Waste to Watts: What Really Drives Biotech’s Carbon Footprint
In this episode of The BioDisruptors Podcast, we explore what it really means to make biologics sustainable. We uncover surprising facts about where the biggest environmental impacts actually come from. It is not the plastic waste most people think of, but the electricity that powers clean rooms and HVAC systems, making up most of the footprint. We discuss how shortening process durations, increasing yields, and switching to renewable energy can dramatically lower emissions while also cutting costs. The conversation shows how sustainability and profitability can go hand in hand, creating a…
E22 · 30 Sep 2025 · 11 min
Ep. 22 Antibody–Drug Conjugates: Precision Weapons in Cancer Therapy
Antibody–drug conjugates, or ADCs, are transforming cancer therapy by combining the precision of monoclonal antibodies with the potency of cytotoxic drugs. In this episode, we explore the science behind ADC design, including the choice of antibody backbones, linker technologies, and payload classes. We also look at lessons learned from early market withdrawals, the resurgence of re-engineered therapies, and how bystander effects shape clinical outcomes. With more than 15 approvals, ADCs represent one of the fastest-growing classes in oncology. Tune in to learn how scientific innovation and…
E21 · 17 Sep 2025 · 27 min
Ep. 21 Layer by Layer: 3D Printing in Healthcare
The promise of 3D printing in healthcare is no longer science fiction. In this episode of BioDisruptors , we dive into how this technology is reshaping patient care with everything from tailor made implants and surgical models to living tissues created from patient cells. We explore the main printing methods used in medicine, the science of bio-inks, and the challenges of maintaining cell health during the printing process. Whether you are curious about the science or the future of medicine, this episode makes complex biotech breakthroughs easy to follow. Featured Article: Process, Material,…
E17 · 2 Sep 2025 · 18 min
Ep. 20 Gene Therapy Vectors Compared: Viral vs Non-Viral
In this episode, we explore the fascinating world of gene therapy vectors, the delivery systems that make genetic medicine possible. We look at how viral vectors such as lentiviruses, adenoviruses, and adeno-associated viruses each bring unique strengths, from powering CAR T cancer treatments to enabling cures for inherited blindness and spinal muscular atrophy. We also unpack the challenges, including risks of insertional mutagenesis, immune reactions, and cargo size limits that continue to drive scientific innovation. Finally, we turn to the fast growing field of non-viral vectors,…
E19 · 19 Aug 2025 · 27 min
Ep. 19 From Clarification to Sterilization: How Filters Safeguard Biopharma
In this episode, we explore how membrane filtration safeguards biopharma products such as antibodies, mRNA vaccines, and viral vectors. We walk through the key steps from microfiltration and ultrafiltration to virus and sterilizing filtration, showing how each stage protects purity and safety. We also examine the major challenge of fouling, where valuable molecules clog the very filters designed to protect them. Finally, we highlight strategies to overcome these obstacles, including prefiltration, advanced membrane materials, and smart process optimization. This episode offers a clear look…
E18 · 13 Aug 2025 · 22 min
Ep. 18 Optimization Breakthrough: Boosting AAV Yields for Affordable Gene Therapies
Gene therapies using recombinant adeno associated (rAAV) viral vectors are offering cures for conditions once thought untreatable, but the enormous cost and complex manufacturing keep them out of reach for many patients. In this episode of The BioDisruptors Podcast, we look at a new manufacturing approach that could change the economics of these treatments. Examining recent research from experts in process development, we explore how a multivariate design of experiments boosted viral vector yields to over one trillion vector genomes per milliliter while improving quality. From the science…
5 Aug 2025 · 25 min
Ep. 17 Copy That Cure: The Cell and Gene Therapy Biosimilar Challenge
Cell and gene therapies are changing how we treat diseases that were once considered untreatable, but their massive price tags are putting serious pressure on health systems. In this episode of BioDisruptors, we explore whether biosimilars, which are lower cost follow-on versions of biologic drugs, can work for these complex therapies. Using insights from experts across regulation, manufacturing, intellectual property, and pricing, we dive into the real challenges and opportunities for biosimilar development in cell and gene therapy. From unclear FDA rules and clinical trial delays to…
E16 · 22 Jul 2025 · 23 min
Ep. 16 Promise and Pressure: Unpacking FDA's Expedited Drug Pathways
In this episode, we unpack how the Food and Drug Administration speeds up drug development for serious and underserved medical conditions. We explore five key designations that accelerate this process: Orphan Drug, Fast Track, Accelerated Approval, Priority Review, and Breakthrough Therapy. You will learn how these programs help bring treatments to patients more quickly and how they are driven by both scientific urgency and public policy goals. We also examine the tradeoffs that come with speed, including smaller clinical trials, more post approval safety changes, and significantly higher…
E15 · 15 Jul 2025 · 16 min
Ep. 15 Animal Free by Design: A Smarter Way to Science
In this episode, we explore the growing shift in biotech to remove animal derived components from research and manufacturing. Materials like fetal bovine serum (FBS), animal sourced antibodies, and extracellular matrix proteins have long supported cell culture and drug development, but they raise serious ethical, scientific, and safety concerns. We dig into why the biopharma industry is moving toward animal origin free alternatives, the problems with traditional inputs, and the innovative solutions replacing them. From chemically defined media and recombinant antibodies to plant based…
E14 · 8 Jul 2025 · 27 min
Ep. 14 Trained to Kill: The Science Behind NK Cell Therapy
Natural killer cells are gaining serious momentum as a promising form of cell therapy in the fight against cancer. This week, we dive deep into the fascinating world of natural killer (NK) cells, our immune system’s fast acting first responders, and how they are being reengineered to take on some of the toughest cancers. We explore how NK cells work, why cancer manages to evade them, and what researchers are doing to overcome these hurdles, from memory like NK cells to powerful CAR engineered therapies and next generation strategies like bispecific engagers and extracellular vesicles. Tune…
E9 · 2 Jul 2025 · 22 min
Ep. 13 Paying for Miracles: The Gene Therapy Dilemma
Gene therapies offer real hope for patients with serious conditions like spinal muscular atrophy and sickle cell disease. These treatments can work with just one dose, but that dose can cost more than three million dollars. So how can we make sure patients who need them can actually get them? In this episode of The BioDisruptors Podcast, we explore the challenges of paying for gene therapy. We explain why these treatments are so expensive, how insurance plans are trying to manage the cost, and what new ideas might help, such as paying based on results or spreading payments over time. If you…
E12 · 17 Jun 2025 · 22 min
Ep. 12 Swallow This: The Oral Vaccine Revolution
In this episode of The BioDisruptors Podcast, we take a deep dive into the cutting edge world of oral vaccines and break down the science behind why the oral route approach is so promising. However, turning a vaccine into a pill is no small feat. The gastrointestinal tract is designed to break things down, creating a hostile environment for fragile molecules like proteins and mRNA. We explore the major biological barriers and the groundbreaking strategies scientists are developing to overcome them. Join us as we unpack the promise, the challenges, and the biotech innovations shaping the…
E11 · 9 Jun 2025 · 22 min
Ep. 11 FDA Says Yes to Lab-Grown Meat: Wildtype’s Cultivated Salmon Gets the Green Light
In this episode, we’re celebrating a major milestone for food innovation. Wildtype has officially received FDA clearance for its cultivated salmon; the first cultivated seafood ever approved for sale in the United States. What makes this especially exciting is how closely the cultivated meat process mirrors the workflows of biopharma. From cell isolation to bioreactor scale-up and media optimization, the tools used to grow meat from cells are straight out of the life sciences playbook. We explore how Wildtype and others are navigating the scientific, technical, and regulatory challenges of…
E10 · 3 Jun 2025 · 25 min
Ep. 10 Smart Chromatography: Purifying Full AAV Capsids from Empties
In this week's episode, we tackle another complex and critical challenge in gene therapy manufacturing: purifying recombinant Adeno-Associated Virus (AAV). Why is it so important to separate full capsids from empty ones—and how can we do it more effectively? Join us as we revisit the fundamentals of chromatography and explore the cutting-edge role of mechanistic modeling in optimizing downstream purification. This episode bridges biology, engineering, and computation to reveal how smarter purification strategies lead to safer, more effective gene therapies. Featured Article: Mechanistic…
E9 · 28 May 2025 · 20 min
Ep. 9 From Hype to the Production Line: How AI Is Transforming Biopharma Manufacturing
In this new episode of The BioDisruptors Podcast, we take you inside one of biotech’s most exciting frontiers: artificial intelligence in biopharmaceutical manufacturing. Moving past the headlines, they explore how AI is making a real impact: from optimizing upstream and downstream bioprocesses to enabling real-time quality control, predictive maintenance, and supply chain resilience. Featured Article: Using Deep Reinforcement Learning for Optimizing Process Parameters in CHO Cell Cultures for Monoclonal Antibody Production ( https://doi.org/10.69987/AIMLR.2024.50302 ) Advancements in…
E8 · 20 May 2025 · 18 min
Ep. 8 Nature’s Safety Test: Horseshoe Crabs and the Future of Endotoxin Testing
For decades, the biopharma industry has relied on horseshoe crab blood to detect dangerous bacterial endotoxins. But with growing ethical, environmental, and scientific concerns, the tides are shifting. We explore the history of pyrogen testing, from rabbit injections to the LAL test, and unpack the science behind these methods. Then, we turn our focus to the emerging recombinant technologies that promise greater specificity, consistency, and sustainability; all without relying on animal sources. Most importantly, we break down the new U.S. Pharmacopeia <86>, a major regulatory milestone…
E7 · 13 May 2025 · 20 min
Ep. 7 Hijacking Biology: Exosome-Associated AAVs in Gene Therapy
Delivering gene therapies to the brain is one of the toughest challenges in biotech. But what if we could hijack the body’s own transport system to do it? In this episode, we dive into a 2016 study on exosome-associated AAV vectors; a clever fusion that improves AAV delivery to the central nervous system. By packaging AAVs inside naturally occurring exosomes, researchers demonstrated enhanced transduction efficiency across the blood-brain barrier, with reduced immune response and broader tissue reach. We explore the mechanisms, the implications for non-invasive CNS gene therapy, and what…
E4 · 6 May 2025 · 29 min
Ep. 6 From Molecules to Medicine: The Complexities of Biologic Formulation
Formulating biologics is one of the most complex steps in drug development, requiring a deep understanding of molecular stability, delivery mechanisms, and regulatory constraints. This episode delves into the intricacies of excipient selection, aseptic manufacturing, and advanced delivery systems like lipid nanoparticles. We explore how formulation choices impact clinical performance and the future of personalized biologic therapies. Featured Articles: Optimizing Excipient Properties to Prevent Aggregation inBiopharmaceutical Formulations (https://doi.org/10.1021/acs.jcim.3c01898) Optimizing…
E5 · 29 Apr 2025 · 22 min
Ep. 5 Where Medicines Begin: Inside the World of Drug Discovery
Wondering how new medicines are discovered and brought to life? We explore the fascinating world of drug discovery — the critical first step in creating new therapies. We’ll walk through how researchers identify, design, and validate treatments, from early scientific breakthroughs to the complex process of developing New Biological Entities ( NBEs ). You'll discover the immense time, cost, and innovation it takes to bring a drug from the lab bench to patients. Whether you’re a biotech enthusiast or simply curious about how new medicines come to life, this episode offers a deeper appreciation…
E4 · 22 Apr 2025 · 27 min
Ep. 4 From Screens to SLCs: What Makes a Good Assay Great
In this episode of The BioDisruptors Podcast, we dive into the art and science of assay development; a critical, yet often overlooked, part of the drug discovery pipeline. We explore Solute Carriers (SLCs), what makes a “good” assay and how thoughtful assay design drives reliable, reproducible results in biopharma research. Along the way, we discuss insights from the Assay Guidance Manual, a gold-standard resourced developed by NCATS and Eli Lilly, and break down findings from a recent Frontier in Pharmacology titled “Advancing drug discovery through assay development: a survey of tool…
E3 · 14 Apr 2025 · 21 min
Ep.3 AAV Gene Therapy Progress and Challenges
In this episode, we dive into the most commonly used viral vector in gene therapy— Adeno-Associated Virus (AAV) . We're breaking down a recent Nature review article published in Signal Transduction and Targeted Therapy , which highlights the latest progress and persistent challenges in AAV-based gene therapies. Tune in for a deep dive into the science and the road ahead for AAV in biotech. Review Article: Adeno-Associated Virus as a Delivery Vector for Gene Therapy of Human Diseases (https://doi.org/10.1038/s41392-024-01780-w)
E2 · 8 Apr 2025 · 29 min
Ep.2 Engineering Parameters in WAVE Bioreactors
In this episode, we take a deep dive into the engineering fundamentals of bioprocessing, focusing on how key engineering parameters—mixing time, power input per volume (P/V), and oxygen transfer rate (kLa)— impact cell culture performance. We’ll explore a study that investigates how these dynamics play out specifically in the WAVE bioreactor, compared to traditional stirred-tank bioreactors. White Paper: Engineering Characterization of ReadyToProcess WAVE 25 Bioreactor System with 20 L Cellbag Culture Chamber
E1 · 30 Mar 2025 · 19 min
Ep.1 Animal Vaccine Production with Perfusion
Perfusion technology for intensifying virus manufacturing processes for animal vaccines. The study investigated the impact on cell density and viral output across different scales and cell lines. White paper: Investigation of XCell ATF® Perfusion Technology for virus manufacturing process intensification at MSD Animal Health
30 Mar 2025 · 3 min
Ep.0 Welcome to The BioDisruptors Podcast!
The BioDisruptors Podcast Launch! Listen now and turn biotech complexity into clarity.

About The BioDisruptors Podcast

The BioDisruptors Podcast is a English tech & science podcast from The BioDisruptors. Melo plays each episode straight from the publisher's own feed — no ads added, no account needed — and remembers where you stopped, in this browser only.

Publisher: The BioDisruptors
Language: English
Category: Tech & Science
New episodes: Weekly
Typical length: 21 min
Latest episode: 22 Jan 2026
Feed: RSS — paste into any podcast app
Apple Podcasts: podcasts.apple.com/podcast/id1805465622
Rights: The BioDisruptors

RSS feed Apple Podcasts

More English tech & science

Take it with you

The Melo app keeps playing with the screen off, works in the car and on your watch, wakes you to your station, and browses the whole catalogue offline. Free, no ads, no account.